IDH1 and neoplasm: Genetic analysis of primary tumour showed IDH1 R132H, TERT C250T, and KRAS G12A (Supplementary Fig. 2), and no mutations in IDH2, H3F3A, or HIST1H3B. MGMT promoter was hypomethylated.